ISOPAQUE 280 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Isopaque 280, and what generic alternatives are available?
Isopaque 280 is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in ISOPAQUE 280 is calcium; meglumine; metrizoic acid. There are two hundred and eighty-two drug master file entries for this compound. Additional details are available on the calcium; meglumine; metrizoic acid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISOPAQUE 280?
- What are the global sales for ISOPAQUE 280?
- What is Average Wholesale Price for ISOPAQUE 280?
Summary for ISOPAQUE 280
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
DailyMed Link: | ISOPAQUE 280 at DailyMed |
US Patents and Regulatory Information for ISOPAQUE 280
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | ISOPAQUE 280 | calcium; meglumine; metrizoic acid | INJECTABLE;INJECTION | 017506-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ISOPAQUE 280
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | ISOPAQUE 280 | calcium; meglumine; metrizoic acid | INJECTABLE;INJECTION | 017506-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ISOPAQUE 280
See the table below for patents covering ISOPAQUE 280 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 1518051 | ⤷ Sign Up | |
United Kingdom | 973881 | ⤷ Sign Up | |
Spain | 271951 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ISOPAQUE 280
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2957286 | C02957286/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66411 22.12.2017 |
0933372 | 13/2008 | Austria | ⤷ Sign Up | PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713 |
2957286 | SPC/GB19/003 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTERED: UK EU/1/17/1179/001(NI) 20170721; UK EU/1/17/1179/002(NI) 20170721; UK EU/1/17/1179/003(NI) 20170721; UK EU/1/17/1179/004(NI) 20170721; UK EU/1/17/1179/005(NI) 20170721; UK EU/1/17/1179/006(NI) 20170721; UK EU/1/17/1179/007(NI) 20170721; UK EU/1/17/1179/008(NI) 20170721; UK EU/1/17/1179/009(NI) 20170721; UK PLGB 50784/0002-0001 20170721; UK PLGB 50784/0003-0001 20170721; UK PLGB 50784/0004-0001 20170721 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |